Robert Fletcher

VP, Marketing

Rob has served as Vice President of Marketing at Shockwave Medical from July 2016. Previously, he was at Medtronic as the Chief Commercial Officer and then Managing Director for a startup joint venture whose aim was to expand access to modern acute cardiovascular care in a major emerging market through a public private partnership — a flagship strategic alliance for the company.

Prior to that he was Senior Director of Global Marketing, leading the marketing function in Medtronic’s interventional cardiology franchise through a period of 30% growth to $1.8B in revenue.

Rob earned his MBA from the Kellogg School of Management at Northwestern University and BS in Chemical Engineering from the University of Florida.

We use cookies to provide you with the best experience on our website. Please consult our Privacy Policy to learn more about the cookies we use and how you can block them. By continuing on this website, you agree to the use of cookies.

We're excited about IVL's potential in aortic stenosis, too!

But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.

Get Crackin with Shockwave IVL Today

Thanks for contacting us! We will get in touch with you shortly.

Wow - you're ready to start cracking, aren't you?

Too bad our coronary technology is not yet approved in the United States. Good news is that we have initiated our U.S. FDA IDE study. Learn more about the Disrupt CAD III study on our clinical research portion of the website.